What's new

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised

Mar 4, 2025 - 13:30
 0
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised
Read More

Tags:

Previous Article

We moved a conference halfway around the globe to avoid visa discrimination

Next Article

The nasty consequences of natural gas price volatility

Related Posts

Withdrawn application: Bimervax, 05/02/2025

Withdrawn application: Bimervax, 05/02/2025

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

EMEA-001619-PIP03-16-M02

EMEA-001619-PIP03-16-M02

Feb 14, 2025  0